Researchers found ECT was a safe for patients with dementia experiencing agitation or aggression, as well as for those with comorbid medical conditions.
Although 11.0% of individuals taking antidepressants developed dementia, only 2.6% of the unexposed sample went on to be diagnosed with dementia.
The FDA has granted Fast Track designation to neflamapimod (EIP Pharma) for the treatment of dementia with Lewy bodies (DLB).
Long sleep duration predicts seven-year cognitive decline among U.S. Hispanic/Latino patients.
Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
Despite potent antiretroviral therapy, HIV-associated dementia results in significant morbidity and mortality.
Income volatility during a 20-year period beginning in young adulthood is associated with worse cognitive function and brain integrity in midlife.
Among US Chinese older adults, oral (teeth and gums) health symptoms are associated with a decline in cognitive function.
Assessment of dementia risk using three common screening tools at baseline predicts incident dementia over the course of about seven years.
Adults aged 65 years and older should undergo annual cognitive health assessments to improve recognition of mild cognitive impairment.